TGTX FY 2021 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TGTXTG Therapeutics, Inc.

$5B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+4300.7% YoY

Gross Profit

$6M88.2% margin

Operating Income

-$345M-5154.3% margin

Net Income

-$348M-5204.1% margin

EPS (Diluted)

$-2.63

Cash Flow

Operating Cash Flow

-$296M

Free Cash Flow

-$296M

Stock-Based Comp.

$61M

Balance Sheet

Total Assets

$380M

Total Liabilities

$142M

Stockholders' Equity

$237M

Cash & Equivalents

$299M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$152,000	+4300.7%
Gross Profit	$6M	$152,000	+3780.9%
Operating Income	-$345M	-$274M	-26.0%
Net Income	-$348M	-$279M	-24.6%